Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Bicalutamide design [Design Issues]

posted by BEAZ – India, 2008-03-31 16:36 (6663 d 18:10 ago) – Posting: # 1730
Views: 4,994

Dear Helmut

Thanks for the input, only R(-)bicalutamide is found to be active why we have to quantify the inactive S(+)metabolite also, as per the FDA's recommendation analyte to be measured is "bicalutamide".

Thanks and Regards

—
Alhas

Complete thread:

Bicalutamide BE BEAZ 2008-03-25 09:49
- Bicalutamide design Helmut 2008-03-26 16:32
  - Bicalutamide designBEAZ 2008-03-31 14:36
    - Racemate vs. enantiomers (EU) Helmut 2008-03-31 15:03

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
251 visitors (0 registered, 251 guests [including 19 identified bots]).
Forum time: 10:47 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz